• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雷帕霉素通过阻碍内皮细胞的增殖和迁移以及诱导内皮祖细胞凋亡,抑制经皮冠状动脉介入术后的再内皮化。

Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and inducing apoptosis of endothelial progenitor cells.

作者信息

Liu Hai-Tao, Li Fei, Wang Wen-Yong, Li Xiao-Jing, Liu Yi-Meng, Wang Rui-An, Guo Wen-Yi, Wang Hai-Chang

机构信息

Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, People's Republic of China.

出版信息

Tex Heart Inst J. 2010;37(2):194-201.

PMID:20401293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2851430/
Abstract

Endothelial-cell function is important in the healing of damaged endothelium after percutaneous coronary artery damage. In 3 different animal models, we sought to determine whether rapamycin (sirolimus) affects the proliferation and migration of endothelial cells and endothelial progenitor cells. First, after we implanted stents in dogs, we found that re-endothelialization was impeded more by drug-eluting stents than by bare-metal stents, 30 days after percutaneous coronary intervention. Second, in vitro in rats, we found that 1-100 ng/mL of rapamycin time- and dose-dependently inhibited proliferation over 72 hr (with effects evident as early as 24 hr) and also dose-dependently induced endothelial progenitor-cell apoptosis. Finally, in vivo in rats, we observed that vascular endothelial growth factor expression was decreased after 5 days of rapamycin treatment. We conclude that rapamycin impedes re-endothelialization after drug-eluting stent implantation by inhibiting the proliferation and migration of coronary endothelial cells, inducing endothelial progenitor-cell apoptosis, and decreasing vascular endothelial growth factor expression in the circulation.

摘要

内皮细胞功能在经皮冠状动脉损伤后受损内皮的愈合过程中很重要。在3种不同的动物模型中,我们试图确定雷帕霉素(西罗莫司)是否会影响内皮细胞和内皮祖细胞的增殖与迁移。首先,在给狗植入支架后,我们发现经皮冠状动脉介入治疗30天后,药物洗脱支架比裸金属支架对再内皮化的阻碍更大。其次,在大鼠体外实验中,我们发现1 - 100 ng/mL的雷帕霉素在72小时内对增殖有时间和剂量依赖性抑制作用(早在24小时就有明显效果),并且还对内皮祖细胞凋亡有剂量依赖性诱导作用。最后,在大鼠体内实验中,我们观察到雷帕霉素治疗5天后血管内皮生长因子表达降低。我们得出结论,雷帕霉素通过抑制冠状动脉内皮细胞的增殖和迁移、诱导内皮祖细胞凋亡以及降低循环中的血管内皮生长因子表达,阻碍了药物洗脱支架植入后的再内皮化。

相似文献

1
Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and inducing apoptosis of endothelial progenitor cells.雷帕霉素通过阻碍内皮细胞的增殖和迁移以及诱导内皮祖细胞凋亡,抑制经皮冠状动脉介入术后的再内皮化。
Tex Heart Inst J. 2010;37(2):194-201.
2
Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells.紫杉醇和西罗莫司对内皮祖细胞和冠状动脉平滑肌细胞的生长和迁移有不同的影响。
EuroIntervention. 2011 May;7 Suppl K:K32-42. doi: 10.4244/EIJV7SKA6.
3
Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization.抗 CD34 抗体固定在西罗莫司洗脱支架表面可增强支架内皮化。
JACC Cardiovasc Interv. 2010 Jan;3(1):68-75. doi: 10.1016/j.jcin.2009.09.015.
4
A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.一项前瞻性随机研究,使用光学相干断层扫描评估冠状动脉依维莫司洗脱支架与紫杉醇洗脱球囊后扩张的金属裸支架在植入后 6 个月时的内皮覆盖和新生内膜增殖情况(OCTOPUS 试验):原理、设计和方法。
EuroIntervention. 2011 May;7 Suppl K:K93-9. doi: 10.4244/EIJV7SKA16.
5
Delayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3beta inhibitor.雷帕霉素涂层支架延迟内皮化可通过添加糖原合成酶激酶-3β抑制剂来恢复。
Cardiovasc Res. 2010 May 1;86(2):338-45. doi: 10.1093/cvr/cvq047. Epub 2010 Feb 17.
6
Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?受损的内皮祖细胞是否参与药物洗脱支架晚期支架内血栓形成和再内皮化过程?
Med Hypotheses. 2008;70(3):512-4. doi: 10.1016/j.mehy.2007.05.055. Epub 2007 Aug 30.
7
In vivo evaluation of a biolimus eluting nickel titanium self expanding stent with overlapping balloon expandable drug eluting and bare metal stents in a porcine coronary model.在猪冠状动脉模型中对一种载生物雷帕霉素的镍钛自膨胀支架与重叠的球囊扩张型药物洗脱支架和裸金属支架进行体内评估。
EuroIntervention. 2009 Jan;4(4):534-41. doi: 10.4244/eijv4i4a90.
8
Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.激活过氧化物酶体增殖物激活受体δ作为预防支架内再狭窄和支架血栓形成的新治疗策略。
Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1534-48. doi: 10.1161/ATVBAHA.115.306962. Epub 2016 Jun 9.
9
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.尽管在急性心肌梗死中成功进行了机械干预,但导丝插入后持续无复流是一个早期且易于获得的死亡风险因素:来自 STRATEGY(单次大剂量替罗非班和西罗莫司洗脱支架与阿昔单抗和裸金属支架治疗急性心肌梗死)和 MULTISTRATEGY(多中心评估单次大剂量替罗非班与阿昔单抗与西罗莫司洗脱支架或裸金属支架治疗急性心肌梗死的研究)试验的汇总分析。
JACC Cardiovasc Interv. 2011 Jan;4(1):51-62. doi: 10.1016/j.jcin.2010.09.016.
10
Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.紫杉醇洗脱球囊后扩张与依维莫司洗脱支架治疗裸金属支架:使用光学相干断层成像术在 6 个月随访时的前瞻性随机研究。
Circ Cardiovasc Interv. 2014 Dec;7(6):760-7. doi: 10.1161/CIRCINTERVENTIONS.113.001146. Epub 2014 Nov 4.

引用本文的文献

1
Review of the Protective Mechanism of Curcumin on Cardiovascular Disease.姜黄素对心血管疾病保护机制的综述
Drug Des Devel Ther. 2024 Jan 30;18:165-192. doi: 10.2147/DDDT.S445555. eCollection 2024.
2
Assessment of the healing process after percutaneous implantation of a cardiovascular device: a systematic review.经皮植入心血管装置后愈合过程的评估:一项系统综述。
Int J Cardiovasc Imaging. 2020 Mar;36(3):385-394. doi: 10.1007/s10554-019-01734-2. Epub 2019 Nov 19.
3
Concentration-dependent effects of rapamycin on proliferation, migration and apoptosis of endothelial cells in human venous malformation.雷帕霉素对人静脉畸形中内皮细胞增殖、迁移和凋亡的浓度依赖性影响。
Exp Ther Med. 2018 Dec;16(6):4595-4601. doi: 10.3892/etm.2018.6782. Epub 2018 Sep 19.
4
Effect of silencing lncRNATUG1 on rapamycin-induced inhibition of endothelial cell proliferation and migration.沉默lncRNATUG1对雷帕霉素诱导的内皮细胞增殖和迁移抑制的影响。
Exp Ther Med. 2018 Sep;16(3):1891-1899. doi: 10.3892/etm.2018.6352. Epub 2018 Jun 26.
5
Long non‑coding RNA SENCR alleviates the inhibitory effects of rapamycin on human umbilical vein endothelial cells.长非编码 RNA SENCR 减轻雷帕霉素对人脐静脉内皮细胞的抑制作用。
Mol Med Rep. 2018 Aug;18(2):1405-1414. doi: 10.3892/mmr.2018.9094. Epub 2018 May 29.
6
Small molecule-mediated induction of miR-9 suppressed vascular smooth muscle cell proliferation and neointima formation after balloon injury.小分子介导的miR-9诱导抑制了球囊损伤后血管平滑肌细胞的增殖和新生内膜形成。
Oncotarget. 2017 Sep 28;8(55):93360-93372. doi: 10.18632/oncotarget.21382. eCollection 2017 Nov 7.
7
Delayed reendothelialization with rapamycin is rescued by the addition of nicorandil in balloon-injured rat carotid arteries.在球囊损伤的大鼠颈动脉中,添加尼可地尔可挽救雷帕霉素导致的内皮再内皮化延迟。
Oncotarget. 2016 Nov 15;7(46):75926-75939. doi: 10.18632/oncotarget.12444.
8
Is There Any Significant Difference in Stent Thrombosis Between Sirolimus and Paclitaxel Eluting Stents?: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.西罗莫司洗脱支架与紫杉醇洗脱支架在支架内血栓形成方面是否存在显著差异?一项随机对照试验的系统评价和荟萃分析。
Medicine (Baltimore). 2016 Feb;95(5):e2651. doi: 10.1097/MD.0000000000002651.
9
Endothelial Repair and Regeneration Following Intimal Injury.内膜损伤后的内皮修复与再生
J Cardiovasc Transl Res. 2016 Apr;9(2):91-101. doi: 10.1007/s12265-016-9677-1. Epub 2016 Jan 21.
10
Angiogenic factors and inflammation in steroid-refractory acute graft-vs-host disease.血管生成因子与类固醇难治性急性移植物抗宿主病中的炎症反应
Transl Res. 2016 Jan;167(1):80-7. doi: 10.1016/j.trsl.2015.06.001. Epub 2015 Jun 9.

本文引用的文献

1
Angiotensin II promotes NO production, inhibits apoptosis and enhances adhesion potential of bone marrow-derived endothelial progenitor cells.血管紧张素II可促进一氧化氮的生成,抑制细胞凋亡,并增强骨髓来源的内皮祖细胞的黏附能力。
Cell Res. 2008 Jul;18(7):792-9. doi: 10.1038/cr.2008.69.
2
Frequency of coronary arterial late angiographic stent thrombosis (LAST) in the first six months: outcomes with drug-eluting stents versus bare metal stents.冠状动脉造影晚期支架血栓形成(LAST)在前六个月的发生率:药物洗脱支架与裸金属支架的疗效对比
Am J Cardiol. 2007 Mar 15;99(6):774-8. doi: 10.1016/j.amjcard.2006.10.033. Epub 2007 Jan 19.
3
Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern.第一代药物洗脱支架植入术后晚期支架内血栓形成:一个值得关注的问题。
Circulation. 2007 Mar 20;115(11):1440-55; discussion 1455. doi: 10.1161/CIRCULATIONAHA.106.666800. Epub 2007 Mar 7.
4
Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications.药物洗脱支架与冠状动脉血栓形成:生物学机制及临床意义
Circulation. 2007 Feb 27;115(8):1051-8. doi: 10.1161/CIRCULATIONAHA.106.675934.
5
Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis.冠状动脉支架植入术后CD34阳性骨髓来源细胞的动员:对再狭窄的影响。
Circulation. 2007 Feb 6;115(5):553-61. doi: 10.1161/CIRCULATIONAHA.106.621714. Epub 2007 Jan 29.
6
Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells.他克莫司或西罗莫司对血管平滑肌细胞和内皮细胞增殖的影响。
J Cardiovasc Pharmacol. 2006 Dec;48(6):286-92. doi: 10.1097/01.fjc.0000248233.22570.8b.
7
Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry.药物洗脱支架时代6906例接受经皮冠状动脉介入治疗患者的结局:DEScover注册研究报告
Circulation. 2006 Nov 14;114(20):2154-62. doi: 10.1161/CIRCULATIONAHA.106.667915. Epub 2006 Oct 23.
8
Circulating endothelial cells in cardiovascular disease.心血管疾病中的循环内皮细胞。
J Am Coll Cardiol. 2006 Oct 17;48(8):1538-47. doi: 10.1016/j.jacc.2006.02.078. Epub 2006 Sep 26.
9
Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.药物洗脱支架在人体中的病理学:愈合延迟和晚期血栓形成风险。
J Am Coll Cardiol. 2006 Jul 4;48(1):193-202. doi: 10.1016/j.jacc.2006.03.042. Epub 2006 May 5.
10
Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia.促红细胞生成素动员的内皮祖细胞通过激活Akt-内皮型一氧化氮合酶增强再内皮化并预防内膜增生。
Circ Res. 2006 Jun 9;98(11):1405-13. doi: 10.1161/01.RES.0000224117.59417.f3. Epub 2006 Apr 27.